Medicine and Dentistry
Pleural Fibrosis
100%
Mesothelial Cell
100%
Disease
100%
Effusion
62%
Histone Deacetylase Inhibitor
50%
Gram-Positive Bacteria
37%
Tetracaine
33%
Pleura Thickening
25%
Frontal Bossing
20%
Macrocephaly
20%
Backache
20%
Hearing Impairment
20%
Facial Nerve Paralysis
20%
Spinal Stenosis
20%
Skeleton
20%
Headache
20%
Clinician
20%
Surgical Decompression
20%
Facial Nerve
20%
Physical Disease by Body Function
20%
Rare Disease
20%
Lower Jaw
20%
Trigeminal Neuralgia
20%
Awareness
20%
Family History
20%
Symptomatic Treatment
20%
Visual Impairment
20%
Autosomal Recessive Disorder
20%
Promoter Region
12%
Collagen Synthesis
12%
Morphology
12%
Mesothelium
12%
Lipoteichoic Acid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pleural Fibrosis
100%
Ropeginterferon Alpha2b
100%
Randomized Controlled Trial
100%
Effusion
62%
Histone Deacetylase Inhibitor
50%
SARS Coronavirus
44%
Gram Positive Bacterium
37%
Lung Infiltrate
33%
Tetracaine
33%
Pleura Thickening
25%
Infection
22%
Lipoteichoic Acid
12%
Symptom
11%
Clinical Study
11%
Proline
11%
Antivirus Agent
11%
Adverse Event
11%
Interferon
11%
Immunology and Microbiology
COVID-19
100%
Ropeginterferon Alpha2b
100%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Cycle Threshold
11%
Reverse Transcription Polymerase Chain Reaction
11%
Interferon Type I
11%
